1. Home
  2. FRST vs AGEN Comparison

FRST vs AGEN Comparison

Compare FRST & AGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Primis Financial Corp.

FRST

Primis Financial Corp.

SELL

Current Price

$15.48

Market Cap

404.3M

Sector

Finance

ML Signal

SELL

Logo Agenus Inc.

AGEN

Agenus Inc.

HOLD

Current Price

$6.08

Market Cap

335.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRST
AGEN
Founded
2004
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
404.3M
335.6M
IPO Year
2006
1999

Fundamental Metrics

Financial Performance
Metric
FRST
AGEN
Price
$15.48
$6.08
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
3
Target Price
$18.94
★ $26.33
AVG Volume (30 Days)
110.1K
★ 1.1M
Earning Date
10-22-2026
11-09-2026
Dividend Yield
★ 2.59%
N/A
EPS Growth
★ 477.27
100.00
EPS
0.68
★ 0.96
Revenue
N/A
★ $42,877,086.00
Revenue This Year
$22.97
$9.64
Revenue Next Year
$8.75
N/A
P/E Ratio
$22.71
★ $6.96
Revenue Growth
N/A
★ 89.95
52 Week Low
$9.68
$2.71
52 Week High
$16.88
$10.19

Technical Indicators

Market Signals
Indicator
FRST
AGEN
Relative Strength Index (RSI) 46.70 33.94
Support Level $15.46 $2.96
Resistance Level $15.80 $8.64
Average True Range (ATR) 0.32 0.62
MACD 0.02 -0.29
Stochastic Oscillator 71.84 0.60

Price Performance

Historical Comparison
FRST
AGEN

About FRST Primis Financial Corp.

Primis Financial Corp is the bank holding company for Primis Bank, providing financial services to individuals and small and medium-sized businesses. Primis Bank offers a wide range of commercial banking services, It focuses on making loans secured mainly by commercial real estate and other types of secured and unsecured commercial loans to small and medium-sized businesses in several industries, as well as loans to individuals for a variety of purposes. The company has two reportable segments: Primis Bank. This segment specializes in providing financing services to businesses in various industries along with consumer and residential loans to individuals. Primis Mortgage. This segment specializes in originating mortgages in a majority of the U.S. The revenue is from Primis Bank.

About AGEN Agenus Inc.

Agenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases. Its primary business is immuno-oncology (I-O), where it advances antibody-based programs designed to activate innate and adaptive immunity, overcome tumor immune evasion, and expand the number of patients who may benefit from immunotherapy. The Company's clinical program includes botensilimab (BOT or AGEN1181), both as a monotherapy and in combination with balstilimab (BAL), alongside a portfolio of other clinical-stage immuno-oncology assets that may be used independently or in combination therapies. The Company operates in the United States, which contributes the majority of its revenue, as well as in other international markets.

Share on Social Networks: